NIH PAR · NIGMS · R35
PAR-27-032: Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESIs) provides support for ESIs with a program of research that aligns with the NIGMS mission.MIRA distributes funding among promising investigators across the country. The goal is to boost scientific productivity and the chances for important breakthroughs.Through this program, investigators can:Receive independent research funding early to start and sustain strong research careers.Explore new, unique research areas in the NIGMS mission.Take on ambitious, creative projects.Shift focus to include emerging techniques and technologies as needed.Devote more time to mentoring trainees in a stable research…
- NOFO number
- PAR-27-032
- Type
- PAR
- Activity code
- R35
- Primary institute
- NIGMS · National Institute of General Medical Sciences
- Clinical trials
- Optional
- Posted
- May 12, 2026
- Opens
- Sep 2, 2026
- Expires
- Feb 7, 2029
Funded projects
NIH RePORTER lists no awards under PAR-27-032 in FY2022–FY2026. Awards usually appear a few months after the first review cycle.
Participating institutes
2 NIH institutes and offices take applications under PAR-27-032. Contact the program officer at the institute that fits your research before applying.
- NIGMS · National Institute of General Medical Sciences
- none
Related notices
NIH lists no related notices for PAR-27-032 yet.
Other open NOFOs for R35
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.